NetworkNewsBreaks Archive - Page 496 of 2176

TuesdayJan 16, 2024 3:47 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Ready to Challenge’ with New Five RS SUV, Reports ‘Road Track’ Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its Mullen Five RS were spotlighted in a recent “Road Track” article. The article noted that the sporty new model, which was revealed at CES 2024, is “ready to challenge Tesla and Lucid in the performance EV space. . . . Known as the Mullen Five RS, this electric crossover promises to bring over 1000 hp and a sub-2.0-second 0-60 mph sprint.” The article provided a background look at Mullen, which was incorporated in 2014 and comprises pieces of Coda Motor Cars and Mullen Motors. Calling the Five RS…

TuesdayJan 16, 2024 3:35 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces New Project Win with Well-Known Tracking-Solutions Partner

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has been awarded a new project with a well-known Canadian industry partner in the tracking-solutions sector. SuperCom announced the new project, noting that it marks another milestone in the company’s journey, “building on the company’s successful history of delivering top-tier services and technologies.” Revenue generation from the new contract is anticipated to start in Q1 2024. According to the announcement, the new project “represents a new chapter in SuperCom’s long-standing collaboration with this partner, transitioning from successful collaboration for providing RF-based tracking…

TuesdayJan 16, 2024 3:27 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Provides Update on Litigation

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today provided an update regarding its litigation with GBB Drink Lab Inc. (“GBB”). In May 2023, GBB filed a lawsuit against FSD Pharma alleging a material breach of a mutual nondisclosure agreement and trade secret misappropriation. FSD Pharma has categorically denied these allegations and filed a motion to dismiss the lawsuit. On Jan. 8, 2024, the court denied the motion to dismiss, which means only that FSD Pharma will now proceed with discovery. The company is confident that…

TuesdayJan 16, 2024 3:14 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies. In a recent human pilot study with seven volunteers, Lexaria demonstrated superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The positive results were sufficient to encourage a much more thorough and expanded investigation. The objective of the new planned studies, as detailed in the announcement, is…

TuesdayJan 16, 2024 2:53 pm

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Third-Quarter 2024 Financial Report

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting on its financial results for the third quarter of fiscal 2024, the period ended Nov. 30, 2023. Numbers to note from the report include quarterly revenue of $6.14 million, which includes the company’s SMS & MMS, Telecommunications Products & Services businesses as well as Big Data, totaled $5.26 million, or 46% decrease, compared to Q3 2023; a quarterly decrease in Telecommunications Products & Services business revenue of $4.22 million or 41% compared to Q3 2023; quarterly Big Data revenue of $.01 million compared to $.19 million in Q3 2023;…

TuesdayJan 16, 2024 2:39 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives. Our primary accomplishments throughout the year included a number of key milestones, such as the completion of a phase 2 clinical trial and the launch of two new preclinical programs targeting the treatment of Alzheimer’s disease and age-related macular degeneration (‘AMD’),” said Eric A. Adams, InMed president and CEO.…

TuesdayJan 16, 2024 2:30 pm

NetworkNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has released a message for its shareholders from CEO Mark Dybul. In the message, Dybul provides an update about key developments the company experienced during 2023, including signing a definitive agreement to combine with the European-based, cutting-edge artificial-intelligence (“AI”) company GEDi Cube; GEDi Cube’s partnership with NVIDIA to expand its multiomic capabilities to multimodal; and consistently achieving “the holy grail of cancer research” in preclinical studies. The company has also scheduled a shareholder meeting on Jan. 25, 2024, to vote…

TuesdayJan 16, 2024 2:19 pm

NetworkNewsBreaks — Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Reports Significant Assay Results at Saskatchewan Project, Upgraded Results in Brazil Project

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has announced initial geochemical assay results from its 2023 drilling program; the program was conducted on the Magnet Ridge Zone at Appia’s Alces Lake Project in northern Saskatchewan. According to the announcement, these significant findings “mark a pivotal milestone” in the company's focus and commitment to advance exploration and development initiatives within the prolific Athabasca Basin area. Highlights of the report include returned assays of up to 1.57 wt.% (15,700 ppm) total rare earth oxides (“TREO”), with…

TuesdayJan 16, 2024 1:14 pm

NetworkNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Selected by Navix Health in ‘Significant Milestone’ Collaboration Advancing Digital Health

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has been selected as an exclusive alcohol data partner by Navix Health, a leading provider of innovative healthcare technologies. Navis Health made the announcement last week. According to the announcement, Navix Health will be integrating SOBRsafe's transdermal detection solutions into its proprietary Navix Hub(TM), which is a fully unified facility and practice management software for behavioral health. “With the integration of the SOBRsafe technology, Navix Hub customers can augment current operations with touch-based alcohol monitoring, the results flowing directly into their client records platform,” the announcement stated. “This collaboration marks…

FridayJan 12, 2024 3:00 pm

NetworkNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Positioned as Go-to Logistics Solution Within USMCA Region

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company reforming cross-border shipping, recently announced the renewed selection of its Fr8App for Amazon Mexico’s domestic shipping within the USMCA region. “This marks the second year that Amazon Mexico has contracted Fr8Tech, in what the CEO Javier Selgas has attributed to the company’s commitment to meeting customers’ needs and continuously improving its platform. This announcement comes just months after Fr8Tech announced the securing of a Request for Quotation (‘RFQ’) from a leading global pharmaceutical giant, for which it was awarded 33 lanes to transport pharmaceutical goods from the U.S. to both Mexico and…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks